Sat.Aug 20, 2022 - Fri.Aug 26, 2022

Safety worries spur Novartis to suspend drug dosing in Huntington’s trial

Bio Pharma Dive

Researchers reported signs of nerve damage in patients treated with the drug branaplam, which is among the most advanced candidates now in testing

Trials 236

What should DTC do?

World of DTC Marketing

Consumers would ask their doctor about an advertised prescription drug in a perfect world. In our REAL world, that isn’t the way it happens. Is there a disconnect between what DTC marketers think will happen and what happens with DTC? The research was straightforward.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Nanorobots: small solutions to big delivery problems

Pharmaceutical Technology

Engineering mini robots to treat diseases may seem like an element of a distant future in sci-fi novels where humans are augmented with machines, but early research to do just that is well underway. Micro and nanorobots for targeted drug delivery are meant to reach hard-to-access parts of the body.

COVID At-Home Antigen Tests: If at First You Don’t Succeed Try, Try and Try Again

The FDA Law Blog

By Lisa M. Baumhardt, Senior Medical Device Regulation Expert & Richard A.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Pfizer follows GSK with positive Phase 3 results for RSV vaccine

Bio Pharma Dive

In a pre-planned interim data analysis, Pfizer said its shot was strongly protective against severe disease and plans to submit the results to regulators this fall

What is pharma’s responsibility for online health information?

World of DTC Marketing

Research has shown that 74% of all U.S. adults use the Internet, and 61% have looked for health or medical information on the Internet. Additionally, 49% have accessed a website that provides information about a specific medical condition or problem.

More Trending

Regen BioPharma files patent on mRNA cancer immunotherapy vaccine

BioPharma Reporter

San Diego headquartered, Regen BioPharma, has filed a provisional patent application filing covering utilization of dendritic cell technologies to augment efficacy of its patented survivin mRNA cancer immunotherapeutic vaccine. Markets & Regulations

Moderna follows Pfizer in asking FDA to approve updated COVID shot

Bio Pharma Dive

The companies are moving quickly to supply vaccines targeting currently circulating omicron variants in time for the Biden administration's planned fall vaccination campaign

Half of cancer deaths are preventable

World of DTC Marketing

Globally, nearly half of deaths due to cancer can be attributable to preventable risk factors, including three leading risks of smoking, drinking too much alcohol, or having a high body mass index, a new paper suggests.

Gilead’s Sunlenca receives EC approval to treat HIV

Pharmaceutical Technology

Gilead Sciences has obtained the European Commission (EC) marketing authorisation for Sunlenca (lenacapavir) injection and tablets to treat human immunodeficiency virus (HIV) infection.

Drugs 97

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Clash of the titans: Moderna sues Pfizer, BioNTech for mRNA patent infringement

Fierce Pharma

Clash of the titans: Moderna sues Pfizer, BioNTech for mRNA patent infringement. zbecker. Fri, 08/26/2022 - 09:02

105
105

Backed by $40M, a biotech startup targets cancer with help from the immune system

Bio Pharma Dive

After several years in stealth, 3T Biosciences is launching publicly with plans to develop newer types of T cell receptor-based treatments

Long COVID but short on treatment options

Pharma Phorum

With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the case with the creation of a treatment for Long COVID.

RNA 107

EC grants approval for BioMarin’s gene therapy to treat Hemophilia A

Pharmaceutical Technology

The European Commission (EC) has granted conditional marketing authorisation (CMA) for BioMarin Pharmaceutical ’s gene therapy, Roctavian (valoctocogene roxaparvovec), to treat adults with severe haemophilia A (congenital Factor VIII deficiency).

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Outsourcing strategists thinking farther ahead than ever: CPHI

Outsourcing Pharma

The groupâs latest report glimpses inside the minds of pharma leaders, who are looking at a productâs full life-cycle development at the preclinical stage. Markets & Regulations

Next-generation RNA technologies: making longer-lasting drugs with a broader reach

Bio Pharma Dive

At least 10 biotechnology startups are trying to use RNA molecules in new ways to make medicines. Here’s a look at where they stand

RNA 263

Sword’s digital musculoskeletal care approach improves mental health; study

Pharma Phorum

A clinical trial has found that a digital care programme for people with musculoskeletal pain developed by Sword Health can improve their productivity at work, even if they also have mental health issues.

PAN-TB’s Phase II trials take a shot at shorter TB regimens

Pharmaceutical Technology

The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) is banking on a collaborative approach to scientific innovation to address the growing problem of drug resistance in tuberculosis (TB).

Drugs 83

Merck and Seagen can't agree on a price for their rumored merger: Bloomberg

Fierce Pharma

Merck and Seagen can't agree on a price for their rumored merger: Bloomberg. kdunleavy. Fri, 08/26/2022 - 08:23

94

Merck backs radiopharmaceutical startup Aktis, joining other high-profile backers

Bio Pharma Dive

The pharma contributed to an $84 million round for the new cancer drugmaker, which attracted Novartis and Bristol Myers Squibb in an earlier fundraise

253
253

Merck chases Bayer/Ionis with fast track for Factor XI drug

Pharma Phorum

The FDA has given a novel anticoagulant from Merck & Co a fast-track designation as a treatment for people with end-stage renal disease (ESRD) who need dialysis, firing a warning short over the bows of a rival programme in development at Ionis and Bayer.

Revealed: the pharma companies leading the way in artificial intelligence

Pharmaceutical Technology

Pfizer and Novartis are among the companies best positioned to take advantage of future artificial intelligence disruption in the pharmaceuticals industry, our analysis shows.

AbbVie fends off patent claim in unusual whistleblower case

Fierce Pharma

AbbVie fends off patent claim in unusual whistleblower case. kdunleavy. Fri, 08/26/2022 - 11:20

94

Ovid turns to gene therapy startup to restock drug pipeline

Bio Pharma Dive

The New York biotech will invest in and develop up to three drugs with Gensaic, an emerging startup aiming to use the viruses that infect bacteria to deliver genetic medicines

Roctavian okay sets up another gene therapy test for Europe

Pharma Phorum

BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe.

MolecuLight’s CEO Anil Amlani Discusses Next Steps for Their Wound Imaging Devices

XTalks

Medical imaging device company MolecuLight is a global leader in applying fluorescence imaging to detect and localize elevated bacterial burden in wounds.

It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery

Fierce Pharma

It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery. Thu, 08/25/2022 - 09:15

94

Novartis begins plans to spin off generic drug business

Bio Pharma Dive

After reviewing multiple options including a possible sale, the Swiss drugmaker said spinning off Sandoz would give the division “greater freedom to operate” and capitalize on newly growing sales

Amazon healthcare push shifts with closure of telehealth service

Pharma Phorum

Amazon’s ambitious plan to disrupt the healthcare category seems to have had a course correction after the online retail giant announced it plans to shut down its telehealth service Amazon Care.

AskBio subsidiary readies to start clinical trials for Huntington’s Disease gene therapy

BioPharma Reporter

BrainVectis, a subsidiary of AskBio, has received clearance from the French authorities to start a Phase 1-2 clinical trial for its novel Huntingtonâs Disease gene therapy, BV-101. Bio Developments

FDA wants Pfizer to study COVID rebound cases with a longer course of Paxlovid

Fierce Pharma

FDA wants Pfizer to study COVID rebound cases with a longer course of Paxlovid. kdunleavy. Mon, 08/22/2022 - 09:40

91

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

Bio Pharma Dive

The biotech successfully brought two medicines to market, but shares have lost most of their value amid sluggish sales

Sales 231

To build diversity into clinical trials, collaborate at the community level

Pharma Phorum

Diversity in clinical trials is a “scientific imperative”, but how can industry bridge the gap between “why” and “how”? Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Getting there, however, is easier said than done.

Is it time to start rethinking mobile clinical trial apps?

Outsourcing Pharma

A leader from the trial financial management specialist suggests apps used in trials could be adjusted to better suit patients, sites and other stakeholders. Patient centricity